EVGN icon

Evogene
EVGN

Overview Fund Activity

14 hedge funds and large institutions have $1.7M invested in Evogene in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
-14
Holders Change %
-50%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
4
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AC
1
Armistice Capital
New York
$598K
2
RIG
2
Renaissance Investment Group
Massachusetts
$30.7K
3
BNP Paribas Financial Markets
3
BNP Paribas Financial Markets
France
$37.5K
4
UBS Group
4
UBS Group
Switzerland
$26.4K
5
TRCT
5
Tower Research Capital (TRC)
New York
$890

Top Sellers

1
LPL Financial
1
LPL Financial
California
$0
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$0
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$0
4
Renaissance Technologies
4
Renaissance Technologies
New York
$0
5
Morgan Stanley
5
Morgan Stanley
New York
$38.7K
Name Holding Trade Value Shares
Change 		Shares
Change %
CC
26
Cypress Capital
Tennessee
– -$260 -40 Closed
Qube Research & Technologies (QRT)
27
Qube Research & Technologies (QRT)
United Kingdom
– -$33 -5 Closed
CAS
28
Coppell Advisory Solutions
Texas
– -$18 -3 Closed
Toronto Dominion Bank
29
Toronto Dominion Bank
Ontario, Canada
– -$130 -2 Closed
1
2